The Latest Breaking News from Antibiotics

Drugs Control Administration seizes fake antibiotics worth ₹22.95 lakh

Drugs Control Administration seizes fake antibiotics worth ₹22.95 lakh

The Hindu · Jan 3, 2024

Scientists hail new antibiotic that can kill drug-resistant bacteria

Zosurabalpin has defeated strains of pneumonia and sepsis in mice, raising hopes for human trials

The Guardian - UK · Jan 3, 2024

55% of patients were prescribed antibiotics for preventive indications, 45% for therapeutic indications: NCDC survey

Over half of the almost 10,000 hospital patients surveyed recently were given antibiotics to prevent infection, rather than to treat it, amidst growing concerns about the rise in resistance to antibiotics.

The Hindu · Jan 3, 2024

‘Millions of women are suffering who don’t have to’: why it’s time to end the misery of UTIs

Urinary tract infections have been a cause of chronic distress for generations of menopausal women. Campaigning journalist Kate Muir argues the problem could be halved if an alternative treatment to antibiotics is better understood. So why isn’t more being done?

The Guardian - UK · Dec 17, 2023

Chewy among nine pet companies accused of selling unapproved medication

FDA accuses companies of violating federal law with sale of antibiotics

The Independent UK · Dec 16, 2023

FDA Flags Chewy for Unapproved Animal Antibiotics Sale

Animals beware! US FDA sniffs out unapproved antibiotics case. Companies like Chewy, others warned. Will the corporate kennel become the watchdog's pan?

Top News · Dec 14, 2023

Antimicrobial resistance now hits lower-income countries the hardest, but superbugs are a global threat we must all fight

Antimicrobial resistance (AMR) is one of the World Health Organization’s most urgent health challenges for the next decade. While AMR is a global threat, a tale of two worlds emerges, highlighting the heightened vulnerability of low- and middle-income countries (LMICs).

The Conversation · Dec 11, 2023

Analyzing the Bullish Opportunities of 3 Biotech Stocks

The biotech industry is well-positioned for solid growth due to rising demand for quality treatments and therapies, a rapidly aging population, adoption of technologies like AI and government initiatives. To leverage these trends, consider investing in quality biotech stocks Innoviva (INVA), Puma Biotechnology (PBYI), and Shionogi (SGIOY). Keep reading….

StockNews.com · Dec 11, 2023

Vaccine for superbugs? New shot shows promise in early tests

A new vaccine, so far tested only in mice, broadly activates the immune system against a wide array of bacteria and fungi.

LiveScience · Dec 7, 2023

Mike Brown obituary

Other lives: Academic pharmacist and pharmaceutical microbiologist who specialised in understanding how bacteria respond to antibiotics

The Guardian - UK · Dec 3, 2023